Charles Schwab Investment Management Inc Dynavax Technologies Corp Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,122,733 shares of DVAX stock, worth $14.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,122,733
Previous 1,137,573
1.3%
Holding current value
$14.5 Million
Previous $12.8 Million
2.09%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding DVAX
# of Institutions
275Shares Held
130MCall Options Held
451KPut Options Held
203K-
Black Rock Inc. New York, NY21.9MShares$283 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.5MShares$162 Million5.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.22MShares$119 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.33MShares$107 Million7.62% of portfolio
-
State Street Corp Boston, MA7.69MShares$99.2 Million0.0% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.63B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...